936801-45-5

Basic information

• Product Name: methyl 3-amino-5-(tert-butyl)-2-methoxybenzoate
• Synonyms: methyl 3-amino-5-(tert-butyl)-2-methoxybenzoate
• CAS NO: 936801-45-5
• Molecular Weight: 237.299
• Mol File: 936801-45-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: methyl 3-amino-5-(tert-butyl)-2-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-amino-5-(tert-butyl)-2-methoxybenzoate(936801-45-5)
• EPA Substance Registry System: methyl 3-amino-5-(tert-butyl)-2-methoxybenzoate(936801-45-5)

Safety Data

• Hazardous Substances Data: 936801-45-5(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 951150-53-1 5-(tert-butyl)-2-methoxy-3-nitrobenzoyl chloride 
• 73469-54-2 5-tert-butyl-2-methoxybenzoic acid 
• 848144-43-4 5-(tert-butyl)-2-methoxy-3-nitrobenzoic acid 
• 1215031-97-2 methyl 5-(tert-butyl)-2-methoxy-3-nitrobenzoate 

Relevant articles and documents

NOVEL BENZAMIDES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS

Heteroaryloxy-substituted benzoic acid amides of general formula I wherein the groups R1 to R7 as well as X and Y are defined according to claim 1, including the tautomers, the stereoisomers, the mixtures and the salts thereof. The compounds according to the invention are suitable for the treatment of respiratory complaints, particularly COPD and asthma.

CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines, such as for example arthritis, pain, cardiovascular disease and cancer.

HETEROCYCLIC CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory, anti-pain or anti-cancer agents. There are further provided m